The multivariate regression showed that a model using expression of TPO and NIS, mutation status of the TERT promoter, high-risk histology (tall cell PTC, PDTC and DHGTC) and tumour tissue localisation (primary tumour/lymph node) performed very well in predicting iodine avidity. The gene discussed is TERT; the disease is neoplasm.